<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32</volume><submitter>Rutledge AC</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>Verifying new reagent or calibrator lots is crucial for maintaining consistent test performance. The Institute for Quality Management in Healthcare (IQMH) conducted a patterns-of-practice survey and follow-up case study to collect information on lot verification practices in Ontario.&lt;h4>Methods&lt;/h4>The survey had 17 multiple-choice questions and was distributed to 183 licensed laboratories. Participants provided information on materials used and approval/rejection criteria for their lot verification procedures for eight classes of testing systems. The case study provided a set of lot comparison data and was distributed to 132 laboratories. Responses were reviewed by IQMH scientific committees.&lt;h4>Results&lt;/h4>Of the 175 laboratories that responded regarding reagent lot verifications, 74% verified all tests, 11% some, and 15% none. Of the 171 laboratories that responded regarding calibrator lot verifications, 39% verified all calibrators, 4% some, and 57% none. Reasons for not performing verifications ranged from difficulty performing parallel testing to high reagent cost. For automated chemistry assays and immunoassays, 23% of laboratories did not include patient-derived materials in reagent lot verifications and 42% included five to six patient materials; 58% of laboratories did not include patient-derived materials in calibrator lot verifications and 23% included five to six patient materials. Different combinations of test-specific rules were used for acceptance criteria. For a failed lot, 98% of laboratories would investigate further and take corrective actions. Forty-three percent of laboratories would accept the new reagent lot in the case study.&lt;h4>Conclusion&lt;/h4>Responses to the survey and case study demonstrated variability in lot verification practices among laboratories.</pubmed_abstract><journal>Practical laboratory medicine</journal><pagination>e00300</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9399155</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice survey.</pubmed_title><pmcid>PMC9399155</pmcid><pubmed_authors>Bailey D</pubmed_authors><pubmed_authors>Chan PC</pubmed_authors><pubmed_authors>Booth RA</pubmed_authors><pubmed_authors>Vandenberghe H</pubmed_authors><pubmed_authors>Stemp J</pubmed_authors><pubmed_authors>Rutledge AC</pubmed_authors><pubmed_authors>Johnston A</pubmed_authors><pubmed_authors>Waite G</pubmed_authors><pubmed_authors>Veljkovic K</pubmed_authors><pubmed_authors>Allen LC</pubmed_authors><pubmed_authors>Edmond P</pubmed_authors><pubmed_authors>Aslan B</pubmed_authors><pubmed_authors>Leung V</pubmed_authors><pubmed_authors>Don-Wauchope A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice survey.</name><description>&lt;h4>Objectives&lt;/h4>Verifying new reagent or calibrator lots is crucial for maintaining consistent test performance. The Institute for Quality Management in Healthcare (IQMH) conducted a patterns-of-practice survey and follow-up case study to collect information on lot verification practices in Ontario.&lt;h4>Methods&lt;/h4>The survey had 17 multiple-choice questions and was distributed to 183 licensed laboratories. Participants provided information on materials used and approval/rejection criteria for their lot verification procedures for eight classes of testing systems. The case study provided a set of lot comparison data and was distributed to 132 laboratories. Responses were reviewed by IQMH scientific committees.&lt;h4>Results&lt;/h4>Of the 175 laboratories that responded regarding reagent lot verifications, 74% verified all tests, 11% some, and 15% none. Of the 171 laboratories that responded regarding calibrator lot verifications, 39% verified all calibrators, 4% some, and 57% none. Reasons for not performing verifications ranged from difficulty performing parallel testing to high reagent cost. For automated chemistry assays and immunoassays, 23% of laboratories did not include patient-derived materials in reagent lot verifications and 42% included five to six patient materials; 58% of laboratories did not include patient-derived materials in calibrator lot verifications and 23% included five to six patient materials. Different combinations of test-specific rules were used for acceptance criteria. For a failed lot, 98% of laboratories would investigate further and take corrective actions. Forty-three percent of laboratories would accept the new reagent lot in the case study.&lt;h4>Conclusion&lt;/h4>Responses to the survey and case study demonstrated variability in lot verification practices among laboratories.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-06-01T02:00:34.744Z</modification><creation>2025-06-01T02:00:34.744Z</creation></dates><accession>S-EPMC9399155</accession><cross_references><pubmed>36035320</pubmed><doi>10.1016/j.plabm.2022.e00300</doi></cross_references></HashMap>